Discovery of a novel AR/HDAC6 dual inhibitor for prostate cancer treatment
Maojun Zhou(Central South University), Yongheng Chen(Hunan Cancer Hospital), Zhuchu Chen(Central South University), Guangyu Xu(Hunan Normal University), Xiaoli Min(Medical Technologies (Czechia)), Yubin Li(Central South University), Huichao Huang(Northeast Forestry University), Hao Zheng(Hunan Normal University), Wenqiang Zhou(Chongqing University), Shuyan Dai(Central South University)
Cited by 21
Related Papers
Recent advances in therapeutic strategies for triple-negative breast cancer
|Journal of Hematology & Oncology|2022|892
Targeting p53 pathways: mechanisms, structures and advances in therapy
|Signal Transduction and Targeted Therapy|2023|857
Thallium pollution in China and removal technologies for waters: A review
|Environment International|2019|269
Thallium contamination in farmlands and common vegetables in a pyrite mining city and potential health risks
|Environmental Pollution|2019|172
Synergistic activation of p53 by inhibition of <i>MDM2</i> expression and DNA damage
|Proceedings of the National Academy of Sciences|1998|161